Jason LaRoche, Director of Clinical Innovation at Janssen Pharmaceuticals, speaks with host Deborah Borfitz about the global efforts launched to shrink the carbon footprint in the clinical trial and healthcare spaces. “If the global healthcare sector were a country, it would be the fifth largest emitter of greenhouse gases, and clinical research is a contributor,” explains LaRoche.
In this episode, LaRoche discusses the pre-competitive space designed to inventory individual trials and their greenhouse gas (GHG) emissions to predict the total GHGs for future studies. He also talks about the semi-public database created to share GHG findings across the industry, how regulators and research organizations worldwide are taking action to diminish their carbon footprint, and the standalone project he developed to significantly reduce the massive waste generated from wearable health devices.
Links from this episode:
Clinical Research News
Janssen Global
Sustainable Healthcare Coalition
The Pistoia Alliance
The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News senior writer, Deborah Borfitz, welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.